Matthew Burge — ASN Events

, ,

Presentations this author is a contributor to:

Time from diagnosis of rectal adenocarcinoma to commencement of long course chemoradiotherapy (LCCRT) for metropolitan versus rural patients referred to a Queensland tertiary referral hospital (#257)

3:00 PM
Hayden Christie
Poster discussion 1

Assessment of time to commencement of neoadjuvant long course chemoradiotherapy (LCCRT) for locally advanced rectal adenocarcinoma patients in a tertiary referral hospital (#369)

3:00 PM
Hayden Christie
Poster discussion 2

Cetuximab use in metastatic colorectal cancer at five large Queensland public hospitals: comparison to key clinical trials (#277)

3:00 PM
Daniel McKavanagh
Poster discussion 1

Is bevacizumab in metastatic colorectal cancer effectiveness comparable to key Pharmaceutical Benefits Scheme submission clinical trials? Usage results from five large Queensland public hospitals (#394)

3:00 PM
Daniel McKavanagh
Poster discussion 2

Assessment of long course chemoradiotherapy (LCCRT) in regards to completion of chemotherapy. The experience of a tertiary referral hospital (#370)

3:00 PM
Hayden Christie
Poster discussion 2

Pathologic response of rectal adenocarcinoma to preoperative long course chemoradiotherapy (LCCRT). An assessment at a tertiary referral hospital (#371)

3:00 PM
Hayden Christie
Poster discussion 2

Locally advanced and metastatic pancreatic cancer: An assessment of the provision of chemotherapy at a tertiary referral hospital (#372)

3:00 PM
Hayden Christie
Poster discussion 2

Rural oncology care via teleoncology and outreach clinics: patient and staff perspectives and comparisons. (#293)

3:00 PM
Holly Wyeth
Poster discussion 1